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The results on serological testing of  blood sera from stallions and mares used for 
breeding and the presence of  the viral genome of  Equine Arteritis Virus (EAV) in 
stallion semen are presented. The blood and semen samples were taken from a horse 
stable on the territory of  the Republic of  Serbia during 2012, 2013 and 2014. Detection 
of  anti-EAV specifi c antibodies in blood sera was performed by the virus neutralization 
test (VNT), and identifi cation of  EAV genome RNA in stallion semen was done by 
reverse-transcriptase polymerase chain reaction (RT-PCR). In 2012, high seroprevalence 
of  EAV was detected in the investigated stable. In total, 45% and 65 % of  stallions and 
mares reacted positive, respectively, and the antibody titre values ranged between 2 and 
10 log2. High seroprevalence was confi rmed in the same animals again in 2013. Out of  
two stallions tested semen samples in 2013, the viral genome was detected by RT-PCR 
in 3 examined semen samples from a seropositive stallion, while EAV was not detected 
in 3 semen samples of  a seronegative stallion. During 2014, 11 semen samples were 
collected from two seropositive stallions. Again, the presence of  EAV was confi rmed 
by RT-PCR in all 8 semen samples originating from the same stallion with the EAV 
genome positive semen result in 2013, whereas the virus was not detected in semen 
samples originating from the second anti-EAV antibody positive stallion. The presence 
of  EAV-specifi c antibodies was confi rmed in the blood sera of  the mares inseminated 
with the semen of  seropositive stallions in 2012 and 2013.
Key words: breeding stallions, semen, Equine arteritis virus, RT-PCR, seroprevalence, 
virus neutralization
INTRODUCTION
Equine viral arteritis (EVA) is an infectious disease that can affect all horse categories, 
including foals, colts, mares, stallions and geldings. The causative agent is Equine 
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arteritis virus (EAV) from the family Arteriviridae. EAV is an enveloped, spherical 
virus with a diameter of  50-70 nm. The genome is a single-stranded RNA with 
approximately 12.7 kb in length [1]. The virus was fi rst isolated in 1953 in the 
USA [2] and since then the disease has been reported in several countries on almost 
all continents. Only Japan, Iceland and New Zealand are considered free of  EVA 
[3]. Virus transmission between horses occurs via the respiratory and genital system 
during 7-14 days of  the acute stage of  the disease. EAV is shed in the secretions of  
infected animals and transmitted to other horses via aerosol particles; however, for 
the occurrence of  the infection, direct and close contact between horses is usually 
required [4,5]. The virus is also shed in urine, aborted foetuses, amniotic fl uid and 
placenta or other excreta of  acute infected horses and can be transmitted to other 
animals by direct contact with the infective material. Virus transmission through the 
semen of  persistently infected stallions is a signifi cant route of  infection, since EAV is 
frequently present in the semen.
Most common clinical signs of  the disease include increased body temperature that 
may reach even 41.8°C and can persist during a period of  2 to 9 days [6]. Progressive 
bronchopneumonia and diverse forms of  enteritis develop in foals and younger 
horses (colts), whereas young foals (aged 1-3 months) can manifest symptoms of  
bronchopneumonia and enteritis at the same time, which rapidly develop to a 
progressive “pneumo-enteric” syndrome [7]. EVA infection can include oedema 
- predominantly of  the eyelids, distal parts of  the limbs and abdomen, as well as 
oedema of  the preputium and scrotum in stallions. Abortions in pregnant mares are 
one of  the most important clinical signs of  the disease. The number of  abortions 
can vary from single ones to massive epidemics, when up to 70% of  pregnant mares 
in the stable can miscarry [6,8]. Abortions commonly occur between the 3rd and 10th 
month of  gestation as a result of  viral infection of  the foetus and amniotic membrane, 
which can cause foetal death and consequently abortion. However, detection of  
EAV-specifi c antibodies in newborn foals, before uptake of  the colostrum, indicates 
that foetal infection does not necessarily has a lethal outcome, i.e., foetal death and 
abortion [8]. In adult horses, EVA infection can be presented in the subclinical form 
[9] without obvious clinical signs and the occurrence of  abortion in mares 10, which 
is determined by the immune status of  the infected animal and by biological properties 
of  the virus [6]. Stallions can be infected chronically, often without clinical signs of  the 
disease, but the virus targets the cells of  the ductus deferens, thus enabling shedding and 
dissemination of  the virus via the ejaculate of  carrier stallions [6]. Even up to 70% of  
stallions, after the infection can remain persistently infected for lifetime [11].
The diagnosis of  EVA is based on laboratory examination. Detection of  anti-EAV 
specifi c antibodies in the blood sera is considered most important for the diagnostic 
examination and is performed by the virus neutralization test (VNT) or ELISA. The 
fi rst anti-EAV antibodies can be detected 7-14 days after infection. The highest levels 
of  antibodies are detectable in the period 2-4 months post infection, and they can 
persist for 3 or more years [6,12]. Antibody titre values higher than 2 log2 are considered 
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positive in VNT [13]. For diagnosis of  EVA infection the following methods for virus 
detection in clinical samples are also very important: virus isolation in susceptible 
cell cultures (RK-13), molecular techniques (RT-PCR) or immunohistochemical 
examination [14]. A certain attention in laboratory testing should be paid to stallions. 
During the past 20 years, different molecular methods  have been developed with 
the aim of  a rapid and effective virus detection in stallion semen, based on reverse 
transcriptase-polymerase chain reaction (RT-PCR) [6,8,11,15].
In the Republic of  Serbia, the diagnosis of  EVA infection has been introduced in 
2002, and covered only imported horses during the quarantine period. Later on, most 
probably because of  increasing awareness of  the importance of  this disease, the 
horse breeders took the initiative towards serological testing of  both stallions and 
mares before mating [16]. So far, a vaccination program against EAV has not been 
implemented in the Republic of  Serbia.
MATERIAL AND METHODS
Animals
The study encompassed horses at a horse stable with an annual raising capacity of  
60 Lipizzaner breed horses of  all categories. In order to detect the presence and 
prevalence of  EVA infection in the examined stable, blood samples from all mares 
and stallions that are used for breeding were collected in 2012 and 2013, as well as 
blood and semen samples from 3 stallions which semen is mostly used for artifi cial 
insemination were collected during 2013 and 2014. At this horse stable, the only 
method for fertilization is artifi cial insemination takes place during spring period 
(April-May). In addition, analysis of  the health status of  all horses on this horse stable 
for the period of  last 5 years was performed. This analysis was performed according 
to anamnestic data obtained from the veterinarians and farm management and by 
evaluating health records data of  all stallions and mares included in this research. To 
provide a clear overview of  collected samples, the data on sampling periods, number, 
origin and type of  samples are presented in Table 1.
Blood samples
Blood was taken from 9 stallions and 20 mares in October 2012, and again in October 
2013 from 7 stallions and 14 mares from the same group of  animals. Blood was taken 
by puncture of  the jugular vein and collected into blood collection tubes. Blood samples 
from 3 stallions, which are used for artifi cial insemination, were additionally collected 
at the same time when semen sampling in 2013 and 2014.
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Table 1. Data on sampling period, origin and type of  samples
Tested animals
Samplings
2012 2013 2014
blood semen blood semen blood semen
Stallion № 1 October ND 24.04.October
24/04/ 
25/04/ 
26/04/
09/05/
09/05/ 
17/05/ 
19/05/
22/05/ A 
22/05/ B
23/05/ A
23/05/ B 
24/05/
Stallion № 2 October ND 24.04.October
24/04/ 
25/04/ 
26/04/
ND ND
Stallion № 3 October ND October ND 25/04/
25/04/ 
26/04/ 
27/04/
Stallions from № 4 to № 7 October ND October ND ND ND
Stallions № 8 and № 9 October ND ND ND ND ND
Mares from № 1 to № 14 October NA October NA ND NA
Mares from № 15 to № 20 October NA ND NA ND NA
ND – not done; NA – not applicable; A – Semen sample collected in the morning; B – Semen 
sample collected in the evening
Semen samples
Semen samples were collected during the mating season using an artifi cial vagina 
(Missouri model, Germany). Immediately after collecting the ejaculate, a volume of  
3 ml semen sample was poured from the collection tube into sterile tubes and stored in 
a freezer at –20°C until testing. For each sampling a sterile lining and sterile collection 
tube were used. In April 2013, 6 semen samples were collected from two stallions 
(3 samples per stallion with a 24-hour interval). Serological examination performed 
in 2012 revealed that one stallion (stallion № 1) was seropositive with a high anti-
EAV antibody titre, while the second one was seronegative (stallion № 2). During 
May 2014 (between 9th and 15th May), 8 semen samples were collected consecutively 
from the same seropositive stallion (stallion № 1) whose semen was previously tested 
in 2013. The samples were collected at different time intervals, of  sequential semen 
collection for artifi cial insemination of  mares. During April 2014, 3 semen samples 
were collected with 24-hour intervals from the second stallion that was seropositive 
(stallion № 3) in 2012 and 2013.
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Virus neutralization test (VNT)
For the detection of  antibodies against EAV in blood serum samples virus neutralization 
test (VNT) was used, according to the procedure prescribed by OIE Terrestrial Manual, 
Chapter 2.5.10 (2008). Virus neutralization test was performed by using rabbit-kidney 
cell line RK-13 (ATCC-CCL-37) and Bucyrus strain of  EAV (CVL Bucirus, APHIS, 
NVSL, Ames, USA). The determined antibody titre values are expressed as binary 
logarithm to base 2 (log2).
Reverse transcriptase-polymerase chain reaction (RT-PCR)
RNA was extracted from each of  17 (6, 3+3, from 2 stallions in 2013, and 8 and 3 
samples from 2 stallions in 2014) homogenized/lysed native stallion semen samples 
using a commercial kit (Qiagen Viral RNA Mini Kit, QIAGEN, Germany) according 
to manufacturer’s instruction. Native semen from the seronegative stallion, artifi cially 
contaminated with the Bucyrus reference strain of  EAV (100 TCID50/0.1mL), 
was used as a positive control for RNA extraction and RT-PCR, and the same 
native semen from a seronegative stallion, not artifi cially contaminated, was used 
as the negative control. The obtained RNA extracts were further amplifi ed by 
reverse transcription – polymerase chain reaction (RT-PCR) using primers: forward 
EAV7.53F: 5’-GGCGACAGCCTACAAGCTACA-3’ and reverse EAV7.256R: 
5’-CGGCATCTGCAGTGAGTGA-3’ that target virus nucleocapsid gene described 
by Balasuriya et al. (2002). One-step RT-PCR amplifi cation was done using commercial 
kit Qiagen OneStep RT-PCR kit chemistry (QIAGEN, Germany) according to 
manufacturer’s instruction and with small modifi cations. Briefl y, the amplifi cation 
reaction was carried out in a volume of  25 μL containing 13.5 μL of  nuclease-free 
water, 5 μL of  5 x PCR buffer, 1 μL of  dNTP mix (containing 10 mM of  each dNTP), 
0.25 μL of  stock solution of  100 μM of  each primer, 1 μL of  one step RT-PCR 
enzyme mix and 4 μL of  RNA template. The amplifi cation conditions (Thermocycler 
Gradient, Eppendorf, Germany) were as follows: reverse transcription stage at 50C 
for 30 min, followed by an initial PCR activation step at 95C for 15 min, 40 cycles of  
95C for 30s, 55C for 60s, 72C for 60s, and a fi nal extension at 72C for 10 minutes. 
Specifi c PCR product of  204 bp was detected and visualised by electrophoresis on 1.5 
agarose gel stained with ethidium bromide.
Virus isolation
Virus isolation was performed using the 6-well microplates. The microplate wells were 
fi lled with 3 ml of  RK-13 cell culture suspension (about 105 cells/mL). After 24 hour 
incubation, semen samples were inoculated onto the 75% confl uent cell monolayer, 
and the EAV isolation was performed according to the procedure recommended 
by OIE Terrestrial Manual, Chapter 2.5.10 (2013). Cytopathogenic effect has not been 
observed after 3 subsequent blind passages (6-day each). Additionally, EAV presence 
in the cell supernatant of  the third blind passages was established by RT-PCR testing.
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RESULTS
The results of  anti-EAV antibodies in the blood sera examined by VNT and detection 
of  EAV in the semen tested by RT-PCR are presented in tables and fi gures, respectively.
Table 2. Detected antibody titre values in blood sera of  stallions and mares, used for breeding 
in 2012 and 2013.
Table 2.  Results of  testing horse blood sera for the presence of  anti-EAV antibodies
Year of  
research
Horse 
category
No. of  
tested 
horses
No. of  horses with antibody titre (titre log
2
)
0 1 2 3 4 5 6 7 8 9 10
2012
Stallion 9 5 0 2 0 0 0 0 1 0 1 0
Mare 20 7 1 0 0 3 4 3 1 0 0 1
2013
Stallion 7 3 0 2 0 0 1 0 0 1 0 0
Mare 14 3 0 1 1 2 2 1 3 1 0 0
Out of  9 stallions and 20 mares examined during 2012, the presence of  anti-EAV 
antibodies was detected in the blood sera of  4 stallions and 12 mares. Antibody titre 
values in the stallions were 2 log2 in 2 stallions, 7 log2 in one and 9 log2 in one stallion. 
In mares, the observed antibody titre values were 4, 5, 6 and 7 log2 in 11 mares and 10 
log2 in one mare.
Figure 1. RT-PCR products from semen samples (from left to right): 1. PCR marker, 100 
bp; 2. Semen of  seropositive stallion (stallion № 1) collected: 24/04/2013;  3. Semen of  
seronegative stallion (stallion № 2), collected: 24/04/2013; 4. Semen of  stallion № 1, collected: 
25/04/2013; 5. Semen of  stallion № 2, collected: 25/04/2013; 6. Semen of  stallion № 1, 
collected: 26/04/2013; 7. Semen of  stallion № 2, collected: 26/04/2013; 8. negative control 
(water), 9. positive control (EAV, Bucyrus strain), 10. PCR marker, 100 bp
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During 2013, 7 stallions and 14 mares were tested for the presence of  anti-EAV 
antibodies. Compared to the year 2012, the number of  examined animals was reduced 
(2 seronegative stallions were sold and 6 seronegative mares were sold or not included 
anymore into the breeding process). The stallions, that were seropositive in 2012, also 
reacted positively in 2013. However, antibody titre values changed and were 2 log2 in 2 
stallions, whereas 5 and 8 log2 were detected in 2 stallions. The presence of  anti-EAV 
antibodies were confi rmed in the same mares in 2012 and 2013, yet with somewhat 
lower titre values ranging from 2 to 8 log2.
In 2013, 6 (3+3) semen samples were collected from a seropositive and a seronegative 
stallion (stallion № 1 and № 2, respectively). The presence of  EAV RNA was 
confi rmed by RT-PCR in all three semen samples originating from the seropositive 
stallion (stallion № 1), whereas the virus RNA was not detected in the samples from 
the seronegative animal (stallion № 2). Detection of  the viral RNA by RT-PCR in 
semen samples is presented in Figure 1. 
In 2014, 8 semen samples from the seropositive stallion (stallion № 1), which was EAV 
RNA positive in 2013, and 3 semen samples from the seropositive stallion (stallion № 
3) were subjected to RT-PCR testing. RT-PCR results are presented in Figure 2.
Both blood sera and semen samples results from stallions, analyzed during 2013 and 
2014, are presented in Table 2.
Figure 2. RT-PCR products from 11 semen samples collected in 2014 (from left to right): 1. 
PCR marker, 100 bp; 2. – 4. Semen samples of  seropositive stallion (stallion № 3), collected: 
25/04, 26/04 and 27/04; 5. – 12. Semen samples of  seropositive stallion (stallion № 1), 
collected: 09/05, 17/05, 19/05, 22/05A, 22/05B, 23/05A, 23/05B, and 24/05; 13. negative 
control (water); 14. EAV - Bucyrus strain, as a positive control, and 15. PCR marker, 100 bp
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Table 3. Results of  serological testing and semen examination
Year of  
research
Stallion mark
Antibody titre 
(log
2
)
No. of  examined 
semen samples
EAV fi nding in
the semen
Positive Negative
2013
№ 1 8 3 3 0
№ 2 0 3 0 3
2014
№ 1 9 8 8 0
№ 3 6 3 0 3
Serological testing of  the mares inseminated with the semen of  examined stallions, 
performed during 2013 and 2014, are presented in Table 3.
Table 4. Anti-EAV antibodies in the blood sera of  mares inseminated with the semen of  
examined stallions 
Stallion 
mark
Mare mark
Antibody fi nding (log
2
) according to the year
2012 2013
S1
M1 5 7
M2 10 8
M3 5 5
M4 6 3
M5 5 6
S2
M6 4 4
M7 4 5
M8 4 4
M9 5 4
M10 6 7
S3
M11 0 0
M12 0 0
M13 0 0
In the virus isolation test, the cytopathogenic effect was not observed after three 
subsequent blind passages. RT-PCR testing of  cell supernatant from the third blind 
passage of  the examined semen samples was negative.
Analysis of  the health status in the period 2010-2014 revealed no evidence of  clinical 
signs of  the disease in either stallions or mares. All mares have been foaled at the 
expected terms, whereas foals did not manifest any health problem. Massive abortions 
have never been recorded at this horse stable, while sporadic abortions could be 
attributed to either physical trauma (immediate physical contact – kicking of  gravid 
mares) or twin-embryo pregnancies.
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DISCUSSION AND CONCLUSIONS
The presence of  EAV-specifi c antibodies in the horse blood serum is one of  the 
evidence of  the presence of  the disease, which has been confi rmed also in our study 
by fi ndings of  high antibody titre values in breeding stallions and mares [6,12,14]. High 
antibody titre and seroprevalence in stallions (45%) and mares (65%), without clinical 
signs strongly suggest the long-lasting presence of  the disease at a horse stable [8]. 
Positive RT-PCR fi nding of  EAV in the semen of  breeding stallions is the key evidence 
for the presence of  EVA, which has been confi rmed in the reports of  numerous 
researchers [11,14,15]. In our study, EAV was detected by RT-PCR in all (11) tested 
semen samples from one (stallion № 1) of  the three examined stallions, during the 
mating season in 2013 and 2014. The presence of  the virus confi rmed in all 11 semen 
samples, from two consecutive years, strongly suggests that some stallions can shed 
the virus in their semen for life, which is in agreement with already published data [11]. 
The virus isolation on RK-13 cell culture was not successful, which can be explained 
by different reasons. Some authors in their studies also detected the virus using RT-
PCR but have failed to isolate EAV on RK-13 cell culture [8]. RT-PCR negative result 
in 3 semen samples from another seropositive stallion (stallion № 3) cannot exclude 
the possibility of  EAV shedding in the semen. This stallion most probably sheds the 
virus intermittently, since we have detected anti-EAV specifi c antibodies in the blood 
sera of  mares inseminated with the semen of  this stallion in 2012 and 2013 (Table 3). 
According to the guidelines by OIE Terrestrial Manual, Chapter 2.5.10, (2013) and report 
of  Belasurya et al. (2013), seroconversion in seronegative mares 4 weeks after artifi cial 
insemination or mating indicates shedding of  EAV in the stallion’s semen. As expected, 
the presence of  the virus in the semen of  the seronegative stallion (stallion № 2) was 
not confi rmed by RT-PCR and examination of  blood sera of  mares inseminated with 
his semen did not reveal seroconversion (Table 3).
The absence of  clinical symptoms of  EVA and particularly the absence of  abortions 
in pregnant mares, which was established by analyzing the 5-year health status of  
animals at this stable, is in accordance with numerous authors that the disease can take 
a subclinical or clinical course depending on the immune status of  the horse [6,8,9]. 
Changing of  the health status in foals, manifested by “pneumo-enteric” syndrome or 
other EVA-associated diseases, have not been detected on this farm, which is attributed 
to strong maternal immunity of  foals obtained by colostrums uptake [6].
Based on the presented results, we can conclude that EAV was detected in the stallion 
semen, which is, according to our knowledge, the fi rst confi rmation of  this virus in 
the Republic of  Serbia. Further research on this disease will be conducted with a 
special emphasis on the characterization of  the detected virus strain, which includes 
sequencing and molecular typing, with the aim to investigate its biological properties 
and its impact on the health status of  the horse population. 
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UTVRĐIVANJE VIRUSA VIRUSNOG ARTERITISA U SEMENU 
PASTUVA U REPUBLICI SRBIJI
LAZIĆ Sava, LUPULOVIĆ Diana, POLAČEK Vladimir, VALČIĆ Miroslav, LAZIĆ 
Gospava, PAŠAGIĆ Enisa, PETROVIĆ Tamaš 
U radu su prikazani rezultati ispitivanja krvnih seruma priplodnih kobila i pastuva i 
utvrđivanje genoma virusa virusnog arteritisa konja (EAV) u semenu pastuva. Ispiti-
vanja su vršena na jednoj ergeli u Republici Srbiji tokom 2012., 2013. i 2014. godine. 
Utvrđivanje EAV vršeno je dokazivanjem antitela u krvnom serumu, virus neutral-
izacionim testom (VNT) i dokazivanjem virusa u semenu pastuva, RT-PCR. Na ispi-
tivanoj  ergeli u 2012. godini utvrđena je visoka seroprevalencija EAV, koja je kod pri-
plodnih pastuva iznosila 45%, a kod prioplodnih kobila 65%, a utvrđene vrednosti titra 
antitela su iznosile od 2 do 10 log2. Visoka seroprevalencija kod istih konja potvrđena 
je i u 2013. godini, a EAV virus je dokazan RT-PCR u svim prikupljenim uzorcima (3) 
semena seropozitivnog pastuva, dok u uzorcima (3) seronegativnog pastuva virus nije 
dokazan. U 2014. godini prikupljeno je 11 uzoraka semena od 2 seropozitivna pastuva. 
Virus EAV je ponovo dokazan RT-PCR u svim uzorcima (8) semena istog pastuva, u 
čijem semenu je ovaj virus dokazan 2013. godine, dok u uzorcima (3) semena drugog 
isptivanog pastuva, virus nije dokazan. U krvnom serumu kobila, koje su osemen-
javane semenom seropozitivnih pastuva 2012. i 2013. godine utvrđeno je prisustvo 
specifi čih antitela protiv EAV.  
